OncologyBench: Latch's 25-Task Multiagent Cancer Benchmark Tops Out at 40% Pass

kenbwork · x · 2026-10-14

Biotech startup Latch introduced OncologyBench, a verifiable benchmark of 25 multistep oncology evaluations (built on 92 component tasks) spanning six stages from detection to outcome, graded deterministically against the original biological result. Of 31 model-harness combinations, Claude Opus 5, Opus 5.5 and Sonnet 5.5 led with 29–40% strict pass rates; Kimi K3 hit 24% and GPT-6 variants 18–21%. Key findings: models with strong analysis skills still fail at reasoning — two-thirds of attempts that got every analysis right failed the final decision — and decision quality varied with the question asker's persona. The benchmark mirrors real oncology workflows, where specialist analyses are synthesized by a decision-maker without access to raw data.

Related event: OncologyBench Launch: Best AI Models Pass Only 29-40% of Oncology Decisions(6 posts)→

Original post →

More from Models

Models channel →